Showing results (121-130 of 162) with videos related to

Sort By:
Pageof 17
Plos One|May 14, 2013
Mithramycin exerts an anti-myeloma effect and displays anti-angiogenic effects through up-regulation of anti-angiogenic factorsEléonore Otjacques, Marilène Binsfeld, Natacha Rocks, et al.
Leukemia & Lymphoma|June 3, 2017
Molecular mechanisms, current management and next generation therapy in myeloma bone diseaseRoy Heusschen, Joséphine Muller, Elodie Duray, et al.
Journal of Hematology & Oncology|December 19, 2024
Bortezomib-releasing silica-collagen xerogels for local treatment of osteolytic bone- and minimal residual disease in multiple myelomaDirk Hose, Seemun Ray, Sina Rößler, et al.
European Journal of Haematology|July 19, 2008
Multiple myeloma--an update on diagnosis and treatmentJo Caers, Isabelle Vande broek, Hendrik De Raeve, et al.
Clinical & Experimental Metastasis|March 29, 2002
Monocyte chemoattractant protein-1 (MCP-1), secreted by bone marrow endothelial cells, induces chemoattraction of 5T multiple myeloma cellsKarin Vanderkerken, Isabelle Vande Broek, Décio L Eizirik, et al.
Acta Ophthalmologica|November 27, 2008
Oral picropodophyllin (PPP) is well tolerated in vivo and inhibits IGF-1R expression and growth of uveal melanomaMario A Economou, Sandra Andersson, Diana Vasilcanu, et al.
Investigative Ophthalmology & Visual Science|June 3, 2008
Oral picropodophyllin (PPP) is well tolerated in vivo and inhibits IGF-1R expression and growth of uveal melanomaMario A Economou, Sandra Andersson, Diana Vasilcanu, et al.
Haematologica|June 14, 2005
Role of the hypoxic bone marrow microenvironment in 5T2MM murine myeloma tumor progressionKewal Asosingh, Hendrik De Raeve, Mark de Ridder, et al.
Oncotarget|June 4, 2015
Increased resistance to proteasome inhibitors in multiple myeloma mediated by cIAP2--implications for a combinatorial treatmentCharlotte Fristedt Duvefelt, Susanne Lub, Prasoon Agarwal, et al.
Haematologica|February 8, 2006
Clinical significance of chemokine receptor (CCR1, CCR2 and CXCR4) expression in human myeloma cells: the association with disease activity and survivalIsabelle Vande Broek, Isabelle Van de Broek, Xavier Leleu, et al.
Pageof 17